Gilead Faces Trimmed Suit Linking Hepatitis Drug, Liver Cancer

Gilead Sciences Inc. and its unit Asegua Therapeutics LLC face a narrowed suit alleging a hepatitis C drug caused a man’s death from liver cancer, after a federal court in Pennsylvania allowed only negligence claims to advance.

Lauren DiCair alleged her father, Bruce DiCair, began using Harvoni in September 2017 and died in December 2018.

DiCair offered enough detail to advance her negligence claims, the US District Court for the Eastern District of Pennsylvania said Tuesday.

Although her allegations “are not as pointed as one would hope,” the court said she offered “sufficient facts to plausibly suggest” Harvoni was negligently ...